Outlook Therapeutics
OTLK
OTLK
15 hedge funds and large institutions have $1.41M invested in Outlook Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$158K | |
| 2 | +$83K | |
| 3 | +$51.7K | |
| 4 |
Jane Street
New York
|
+$26K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25K |
Top Sellers
| 1 | -$118K | |
| 2 | -$58K | |
| 3 | -$40K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.61K |